Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.

ANAVEX3-71

Small molecule · Modulator of sigma-1 receptor (SIGMAR1) and muscarinic acetylcholine receptor M1 (CHRM1) · developed by Anavex Life Sciences

Phase 2 Most advanced trial
AVXL Developer
2 Registered trials

What is ANAVEX3-71?

ANAVEX3-71 is an oral small molecule that acts as an agonist at the sigma-1 receptor (SIGMAR1) and as a positive allosteric modulator with agonistic effects at the M1 muscarinic acetylcholine receptor. It is being studied in schizophrenia, including its positive, negative and cognitive symptom domains.

Summary written with AI from the sources listed at the end of this page.

At a glance

Drug type
Small molecule
Targets
sigma-1 receptor (SIGMAR1), muscarinic acetylcholine receptor M1 (CHRM1)
Mechanism
Modulator of sigma-1 receptor (SIGMAR1) and muscarinic acetylcholine receptor M1 (CHRM1)
Therapy area
Psychiatry
Developer
Anavex Life Sciences Corp. (AVXL)
FDA status
Investigational, not approved in the US. Most advanced trial: Phase 2

🧪 Clinical trials

TrialPhaseConditionStatusSponsor
NCT06245213 Phase 2 Schizophrenia Active not recruiting AVXL
NCT04442945 Phase 1 Healthy Completed AVXL

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

SchizophreniaHealthy

Other drugs acting on SIGMAR1 / CHRM1

More from Anavex Life Sciences

Sources

Updated Nov 8, 2026. Something wrong or missing? Report it on the AVXL page.

Follow AVXL, the company behind ANAVEX3-71

See AVXL's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.

AVXL catalysts and pipeline →
Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.